Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Molecular Weight | 910.8 g/mol |
---|---|
Molecular Formula | C43H42O22 |
XLogP3 | -2 |
Hydrogen Bond Donor Count | 15 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 10 |
Exact Mass | 910.21677296 g/mol |
Monoisotopic Mass | 910.21677296 g/mol |
Topological Polar Surface Area | 407 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 2100 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 4 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
92
PharmaCompass offers a list of Safflower Yellow API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Safflower Yellow manufacturer or Safflower Yellow supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Safflower Yellow manufacturer or Safflower Yellow supplier.
PharmaCompass also assists you with knowing the Safflower Yellow API Price utilized in the formulation of products. Safflower Yellow API Price is not always fixed or binding as the Safflower Yellow Price is obtained through a variety of data sources. The Safflower Yellow Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LIPOSYN 20% manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LIPOSYN 20%, including repackagers and relabelers. The FDA regulates LIPOSYN 20% manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LIPOSYN 20% API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LIPOSYN 20% manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LIPOSYN 20% supplier is an individual or a company that provides LIPOSYN 20% active pharmaceutical ingredient (API) or LIPOSYN 20% finished formulations upon request. The LIPOSYN 20% suppliers may include LIPOSYN 20% API manufacturers, exporters, distributors and traders.
click here to find a list of LIPOSYN 20% suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A LIPOSYN 20% DMF (Drug Master File) is a document detailing the whole manufacturing process of LIPOSYN 20% active pharmaceutical ingredient (API) in detail. Different forms of LIPOSYN 20% DMFs exist exist since differing nations have different regulations, such as LIPOSYN 20% USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A LIPOSYN 20% DMF submitted to regulatory agencies in the US is known as a USDMF. LIPOSYN 20% USDMF includes data on LIPOSYN 20%'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The LIPOSYN 20% USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of LIPOSYN 20% suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a LIPOSYN 20% Drug Master File in Korea (LIPOSYN 20% KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of LIPOSYN 20%. The MFDS reviews the LIPOSYN 20% KDMF as part of the drug registration process and uses the information provided in the LIPOSYN 20% KDMF to evaluate the safety and efficacy of the drug.
After submitting a LIPOSYN 20% KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their LIPOSYN 20% API can apply through the Korea Drug Master File (KDMF).
click here to find a list of LIPOSYN 20% suppliers with KDMF on PharmaCompass.
LIPOSYN 20% Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LIPOSYN 20% GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LIPOSYN 20% GMP manufacturer or LIPOSYN 20% GMP API supplier for your needs.
A LIPOSYN 20% CoA (Certificate of Analysis) is a formal document that attests to LIPOSYN 20%'s compliance with LIPOSYN 20% specifications and serves as a tool for batch-level quality control.
LIPOSYN 20% CoA mostly includes findings from lab analyses of a specific batch. For each LIPOSYN 20% CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LIPOSYN 20% may be tested according to a variety of international standards, such as European Pharmacopoeia (LIPOSYN 20% EP), LIPOSYN 20% JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LIPOSYN 20% USP).